OncoTargets and Therapy
Volume 9, 2016 - Issue
Open access
61
Views
1
CrossRef citations to date
0
Altmetric
Review
Emerging treatment options for myelofibrosis: focus on pacritinib
Vivian Chow1 Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, CA, USA
, Ashley Weissman2 Department of Pharmacy, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
, Casey Lee O’Connell3 Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
, Azim Mehrvar4 Mahak Children’s Cancer Treatment and Research Center, Tehran, Iran
& Mojtaba Akhtari3 Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USACorrespondence[email protected]
Pages 2655-2665
|
Published online: 04 May 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.